Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Non-Current Debt (2018 - 2024)

Historic Non-Current Debt for ImmunoTech (AIM) over the last 4 years, with Q3 2024 value amounting to $139000.0.

  • ImmunoTech's Non-Current Debt changed N/A to $139000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $139000.0, marking a year-over-year change of. This contributed to the annual value of $3.9 million for FY2019, which is 6867.99% up from last year.
  • According to the latest figures from Q3 2024, ImmunoTech's Non-Current Debt is $139000.0.
  • Over the past 5 years, ImmunoTech's Non-Current Debt peaked at $4.2 million during Q1 2020, and registered a low of $139000.0 during Q3 2024.